๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

231 EFFECT OF ANTIVIRAL THERAPY ON CELL MEDIATED IMMUNITY IN LIVER TRANSPLANT RECIPIENTS WITH HCV

โœ Scribed by G.A. Woo; L. Arosemena; P. Tryphonopoulos; N. Agresti; W. Butt; S. Sclair; E.R. Schiff; A.G. Tzakis; P. Martin

Book ID
117380443
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
53 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term histological effects of preemp
Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection
โœ Alexander Kuo; Vivian Tan; Billy Lan; Mandana Khalili; Sandy Feng; John P. Rober ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 197 KB

The long-term effects of preemptive antiviral therapy on fibrosis progression in liver transplant recipients with hepatitis C virus (HCV) were examined in a cohort of consecutive liver transplant recipients who received preemptive antiviral therapy for 48 weeks (95% were virologic nonresponders). Co

A prospective cross-over study comparing
A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection
โœ Amany Zekry; Margret Gleeson; Seren Guney; Geoffrey W. McCaughan ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB ๐Ÿ‘ 1 views

It has been suggested that Mycophenolate Mofetil (MMF) may have an antiviral effect in patients with recurrent HCV infection post-liver transplantation. We conducted a prospective cross-over study in liver transplant recipients with recurrent chronic HCV infection to examine whether substitution of